Posted by & filed under Company Analysis, Growth & Valuation, Personal Finance.

Description: Danaher will buy the biopharmaceutical business of General Electricin a $21.4 billion deal, the companies announced Monday.

Source: – video report

Date: Feb 25, 2019


Questions for discussion:

  • What motivated the deal for each firm?
  • Explain the rise in stock values?
  • Is this deal good for GE investors in the long run?

Leave a Reply

Your email address will not be published. Required fields are marked *